Pathophysiology of Cerebral Malaria
- 1 May 2003
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 992 (1), 30-38
- https://doi.org/10.1111/j.1749-6632.2003.tb03135.x
Abstract
Cerebral malaria (CM), one of the most serious complications of Plasmodium falciparum infection, is characterized by the sequestration of infected erythrocytes (IEs) in cerebral microvascular beds. The precise mechanisms involved in the onset of neuropathology remain unknown, but parasite sequestration in the brain, metabolic disturbances, and host immune responses all play a role. Studies in a murine model of CM showed a potential role for host cells, especially platelets, in the pathogenesis of CM. Indeed, urokinase plasminogen activator receptor (uPAR; CD87) deficiency attenuates the severity of CM, most likely by its important role in platelet kinetics and trapping. These results led us to evaluate whether platelets have a role in the human disease. By immunostaining of brain samples from Malawian patients, we determined that the surface of platelet accumulation and the proportion of vessels filled with platelets were significantly higher in patients who died of CM than in those who died of other causes. We then investigated the role of platelets in IE cytoadhesion in vitro, using CD36-binding IE (IECD36) and CD36-deficient (CD36DEF) brain microvascular endothelial cells (ECs). Coincubation studies indicated that platelets can induce strong IECD36 binding to CD36DEF ECs and, conversely, can hide constitutively expressed falciparum receptors such as chondroitin sulfate A. Thus, platelets may provide an adhesion receptor to microvascular beds originally devoid of it. This novel mechanism of cytoadhesion may reorient the sequestration of different parasite phenotypes and play an important role in the pathogenesis of severe malaria.Keywords
This publication has 26 references indexed in Scilit:
- Requirement for Tumor Necrosis Factor Receptor 2 Expression on Vascular Cells To Induce Experimental Cerebral MalariaInfection and Immunity, 2002
- Delayed Mortality and Attenuated Thrombocytopenia Associated with Severe Malaria in Urokinase- and Urokinase Receptor-Deficient MiceInfection and Immunity, 2000
- Severe falciparum malariaTransactions of the Royal Society of Tropical Medicine and Hygiene, 2000
- Transgenic mice expressing high levels of soluble TNF‐R1 fusion protein are protected from lethal septic shock and cerebral malaria, and are highly sensitive to Listeria monocytogenes and Leishmania major infectionsEuropean Journal of Immunology, 1995
- Cerebral malaria: The sequestration hypothesisParasitology Today, 1994
- The cytokine theory of human cerebral malariaParasitology Today, 1994
- Human vascular endothelial cell adhesion receptors for Plasmodium falciparum-infected erythrocytes: roles for endothelial leukocyte adhesion molecule 1 and vascular cell adhesion molecule 1.The Journal of Experimental Medicine, 1992
- Relevance of the squirrel monkey as a model for experimental human malariaResearch in Immunology, 1991
- Late administration of monoclonal antibody to leukocyte function‐antigen 1 abrogates incipient murine cerebral malariaEuropean Journal of Immunology, 1991
- Tumor Necrosis Factor (Cachectin) as an Essential Mediator in Murine Cerebral MalariaScience, 1987